Skip to main content Skip to navigation

Disease modifying drug therapy what you need to know

Published May 2012


Contents

Disease modifying drug therapy cover
An introduction to disease modifying drug therapy
What is MS?
What are disease modifying drugs?
Disease modifying drugs licensed for MS
Beta interferon and glatiramer acetate
Natalizumab
Fingolimod
Switching or discontinuing treatment
Treatments in development
Tips for discussing disease modifying drug therapy
Questions to ask
Disease modifying drug webcast
Further sources of information and support

Authors

Karen Alldus, Simon Webster
Information Officers, MS Trust

The MS Trust is a UK charity for people with MS, their family and friends. The MS Trust Information Service offers a personalised enquiry service; produces a wide range of publications including Open Door, a quarterly newsletter; and provides web based information.

Thank you to

  • All the people with MS who reviewed this book and made invaluable.

Please contact the MS Trust information team if you would like any further information about the reference sources used in the production of this publication.